Clinical Trials on IDH1-mutant Cholangiocarcinoma in United Kingdom
Total 442 results
-
Memorial Sloan Kettering Cancer CenterAgios Pharmaceuticals, Inc.RecruitingChondrosarcoma | IDH1 Gene Mutation | Chondrosarcoma, Grade 2 | Chondrosarcoma, Grade 3United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCholangiocarcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v7 | Stage IIIA Gallbladder Cancer AJCC v7 | Stage IIIB Gallbladder Cancer AJCC v7 | Stage IV Gallbladder Cancer AJCC v7 | Stage IVA Gallbladder Cancer AJCC v7 | Stage... and other conditionsUnited States
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
Servier Affaires MédicalesRecruitingCholangiocarcinomaFrance, Netherlands, Spain, Belgium, Sweden, Italy, Australia, Austria, Germany, United Kingdom
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowActive, not recruitingGastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene MutationUnited Kingdom
-
University of California, San FranciscoParker Institute for Cancer Immunotherapy; The V Foundation; Alliance for Cancer...RecruitingDiffuse Midline Glioma, H3 K27M-MutantUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
University College, LondonCompletedGallbladder Cancer | Extrahepatic Bile Duct CancerUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingDiffuse Midline Glioma, H3 K27M-MutantUnited States
-
Jonsson Comprehensive Cancer CenterNot yet recruitingDiffuse Hemispheric Glioma, H3 G34-MutantUnited States
-
D. Kim Turgeon, MDUniversity of WashingtonCompleted
-
Weill Medical College of Cornell UniversityTerminatedCholangiocarcinomaUnited States
-
TransThera Sciences (Nanjing), Inc.RecruitingCholangiocarcinomaKorea, Republic of, United States, Spain, Taiwan, France, Belgium, Germany, Italy, Portugal, United Kingdom, Austria, Poland
-
University Hospital Plymouth NHS TrustUniversity of PlymouthCompletedPancreatic Cancer | Surgery | Bile Duct Cancer | Pancreatic Ductal Adenocarcinoma | Survivorship | Cholangiocarcinoma, Extrahepatic | Cancer Recurrence | Recurrent Cancer | Pancreatic Ductal Carcinoma | Cholangiocarcinoma of the Extrahepatic Bile Duct | Ampullary Cancer | Cholangiocarcinoma Resectable | Cancer... and other conditionsSpain, United Kingdom, Australia, Austria, Italy, Mexico, Sudan, Pakistan
-
EpicentRx, Inc.TerminatedCholangiocarcinomaUnited States
-
University of Alabama at BirminghamSociety of Abdominal RadiologyCompletedCholangiocarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBTG International Inc.CompletedCholangiocarcinomaUnited States
-
Washington University School of MedicineTerminatedCholangiocarcinomaUnited States
-
Danielle Kim TurgeonTerminated
-
Genoscience PharmaTerminatedHepatocellular Carcinoma | Cholangiocarcinoma, IntrahepaticFrance, United States, Belgium
-
University of New MexicoTerminatedCholangiocarcinomaUnited States
-
Roswell Park Cancer InstituteGenentech, Inc.CompletedCholangiocarcinomaUnited States
-
Georgetown UniversityActive, not recruiting
-
Georgetown UniversityAstraZenecaRecruitingBiliary Tract Cancer | Borderline Resectable CarcinomaUnited States
-
Oncolytics BiotechMontefiore Medical CenterCompletedKRAS Mutant Metastatic Colorectal CancerUnited States
-
Methodist Health SystemEnrolling by invitationMetastatic Cancer | Intrahepatic Cholangiocarcinoma | Liver Tumor | Metastatic Liver CancerUnited States
-
National Cancer Institute (NCI)RecruitingColorectal Neoplasms | Colorectal Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bile Duct Neoplasms | Metastatic Colorectal Cancer (Mcrc) | Intrahepatic Cholangiocarcinoma (Icc) | Intrahepatic Bile Duct CancerUnited States
-
The Christie NHS Foundation TrustCancer Research UKCompletedCholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer | Ampullary CancerUnited Kingdom
-
Delcath Systems Inc.Active, not recruitingBile Duct Cancer | Intrahepatic CholangiocarcinomaUnited States
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCholangiocarcinoma | Biliary CancerUnited States
-
Jordan KharofaWithdrawn
-
Mercy ResearchCompletedHepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver MetastasesUnited States
-
University of UtahTerminated
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Jonsson Comprehensive Cancer CenterNot yet recruitingDiffuse Hemispheric Glioma, H3 G34-MutantUnited States
-
Johns Hopkins UniversityRecruitingCholelithiasis | Choledocholithiasis | Biliary Stricture | Cholangiocarcinoma, Intrahepatic | Biliary StonesUnited States
-
Weill Medical College of Cornell UniversityTerminatedCholangiocarcinoma Non-resectable | Unresectable Pancreatic CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
Washington University School of MedicineCompletedPancreatic Cancer | Gallbladder Cancer | Ampullary Cancer | Cholangiocarcinoma CancerUnited States
-
Arog Pharmaceuticals, Inc.CompletedD842-related Mutant GISTUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
GenfitRecruitingCholangiocarcinomaUnited States, Puerto Rico
-
Nathan Bahary, MDBayerCompletedMetastatic Biliary Tract CarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruitingMelanoma | Pancreatic Cancer | Cholangiocarcinoma Metastatic | Liver Malignant TumorsUnited States
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
University of California, DavisNational Cancer Institute (NCI)RecruitingOligoprogressive | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Small Bowel Cancer | Intrahepatic Cholangiocarcinoma | Gall Bladder Cancer | Extrahepatic Cholangiocarcinoma | Appendiceal Cancer | Biliary Cancer | Gastroesophageal-junction CancerUnited States
-
Incyte CorporationCompletedCholangiocarcinomaUnited States, France, Italy, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Korea, Republic of, Japan, Thailand